Skip to content

Advertisement

Open Peer Review Reports for: Herceptin® (trastuzumab) in HER2-positive early breast cancer: protocol for a systematic review and cumulative network meta-analysis

Back to article

Pre-publication versions of this article are available by contacting info@biomedcentral.com.

Original Submission
5 May 2017 Submitted Original manuscript
23 Jun 2017 Reviewed Reviewer Report - Zahra Madjd
14 Jul 2017 Reviewed Reviewer Report - Xavier Armoiry
14 Aug 2017 Author responded Author comments - Florence Wilson
Resubmission - Version 2
14 Aug 2017 Submitted Manuscript version 2
31 Aug 2017 Reviewed Reviewer Report - Xavier Armoiry
12 Sep 2017 Author responded Author comments - Florence Wilson
Resubmission - Version 3
12 Sep 2017 Submitted Manuscript version 3
22 Sep 2017 Reviewed Reviewer Report - Xavier Armoiry
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
28 Sep 2017 Editorially accepted
10 Oct 2017 Article published 10.1186/s13643-017-0588-2

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.

You can find further information about the peer review system here.

Advertisement